Osteosarcoma Recurrent
8 clinical trials · Condition
◉ Watch Osteosarcoma Recurrent
| Record | Firm | Date |
|---|---|---|
| SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma (NCT04803877) | Sarcoma Alliance for Research through Collaboration | 2021-06-04 |
| Olaparib With Ceralasertib in Recurrent Osteosarcoma (NCT04417062) | Dana-Farber Cancer Institute | 2020-11-24 |
| An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer (NCT04651569) | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | 2020-10-02 |
| Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma (NCT04651179) | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | 2020-04-24 |
| Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma (NCT03628209) | H. Lee Moffitt Cancer Center and Research Institute | 2019-10-03 |
Track Osteosarcoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.